Regulation And Legal
Aurobindo Pharma US FDA Raleigh Plant VAI Classification
Aurobindo Pharma's US subsidiary Aurolife Pharma received VAI classification from US FDA for its Raleigh plant after March-April 2025 inspection.
The facility received 11 observations in Form 483 but
